Chu Saint-Etienne
Saint-Etienne, France
NCT Number: NCT04821011
Prematurity birth lead to an early breaking link with the in utero environment. A special attention is brought in the neonatal intensive care units to reduce noise and lighting surrounding aiming to protect the newborn.
During the uterine life fetus benefits previously of several auditory stimulations by the maternal voice, the mother's heartbeat. After birth the auditory environment is dramatically modified.
Aim of this study is to submit to the newborn an audio recording of his mother's heart beat to analyze the comfort, stress and autonomic response. Heart rate variability (HRV) analysis is a non-invasive tool able to consider autonomic nervous system activity. Previous studies have shown that pleasant feelings are associated with an increase of high frequencies variations index (HFnu index) reflecting a prevalence of parasympathetic activity in the sympathetic-parasympathetic balance. This one can be simply assess by a monitor named NIPΣ and can provide a comfort index by quantifying the parasympathetic tone.
Looking for future studies?
Notify Me4 day–10 day
All sexes
Observational
Saint-Etienne, France
The study will imply 40 preterm and term newborns hospitalized in neonatal intensive care units of the University Hospital of Saint-Etienne (France).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Record of maternal heart sounds (heartbeats) with an electronic stethoscope during 10 minutes.
Other names: Littmann® Electronic 3200
Each newborn included will have 20 minutes of an acoustic listening of their mother heartbeats previously recorded.
Recording of the newborn's heart rate: one hour before the acoustic listening, during the acoustic listening and one hour after the acoustic listening .
The variations of the autonomic nervous system will be analyzed.
An coupled Heart rate variability recording (ECG signal obtained from a Philips® IntelliVue MX700 monitor) and NIPΣ index of comfort (MDMS® NIPΣ monitor) will be used.
Other names: Philips® IntelliVue MX700 monitor; MDMS® NIPΣ monitor
Time frame: During the acoustic listening
Analyze variations of the activity of the autonomic nervous system (R-R cardiac interval)
NIPΣ index (from 0 to 100) obtained from an MDoloris® monitor.
The base line is measured one hour before
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
The base line is measured one hour before
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: One hour the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: One hour after the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: During the acoustic listening
Measured by analyze of record's of newborn heart rate.
Time frame: One hour after the acoustic listening
Analyze variations of the activity of the autonomic nervous system (R-R cardiac interval)
NIPΣ index (from 0 to 100) obtained from an MDoloris® monitor.
Centre Hospitalier Universitaire de Saint Etienne
Other
Acronym: Cardio_Sound
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718516
Body Weight, Body Weight Changes
New York, United States
View Trial DetailsNCT03673709
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Blantyre, Malawi
View Trial DetailsNCT07693530
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07661511
Female Urogenital Diseases and Pregnancy Complications, Hypothermia Neonatal
Querétaro, Mexico
View Trial Details